Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Citius Pharmaceuticals Inc banner

Citius Pharmaceuticals Inc
NASDAQ:CTXR

Watchlist Manager
Citius Pharmaceuticals Inc Logo
Citius Pharmaceuticals Inc
NASDAQ:CTXR
Watchlist
Price: 0.7406 USD 11.28% Market Closed
Market Cap: $15.4m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

Assets
+
3Y
+15%
5Y
+199%
10Y
+18 605%
Liabilities
+
3Y
+466%
5Y
+528%
10Y
+4 428%
Equity
+
3Y
-34%
5Y
+100%
10Y
-

Balance Sheet Decomposition
Citius Pharmaceuticals Inc

Balance Sheet
Citius Pharmaceuticals Inc

Rotate your device to view
Balance Sheet
Currency: USD
Sep-2011 Sep-2012 Sep-2013 Sep-2014 Sep-2015 Sep-2016 Sep-2017 Sep-2018 Sep-2019 Sep-2020 Sep-2021 Sep-2022 Sep-2023 Sep-2024 Sep-2025
Assets
Cash & Cash Equivalents
0
0
0
2
1
0
3
9
8
14
70
42
26
3
4
Cash Equivalents
0
0
0
2
1
0
3
9
8
14
70
42
26
3
4
Total Receivables
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
Inventory
0
0
0
0
0
0
0
0
0
0
0
0
0
8
22
Other Current Assets
0
0
0
0
0
1
0
0
0
0
3
3
8
3
1
Total Current Assets
0
0
0
2
1
1
3
10
8
14
73
45
34
14
28
PP&E Net
0
0
0
0
0
0
0
0
0
1
1
1
0
0
1
PP&E Gross
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Accumulated Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Intangible Assets
0
0
0
0
0
19
19
19
19
19
59
59
59
93
93
Goodwill
0
0
0
0
0
2
2
2
9
9
9
9
9
9
9
Other Long-Term Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
0
0
0
0
0
2
2
2
9
9
9
9
9
9
9
Total Assets
0
N/A
0
N/A
0
N/A
2
N/A
1
-56%
22
+3 043%
24
+11%
31
+27%
37
+18%
44
+19%
142
+225%
114
-20%
104
-9%
117
+13%
131
+12%
Liabilities
Accounts Payable
0
0
0
0
1
1
1
2
3
2
1
1
3
5
14
Accrued Liabilities
0
0
0
0
0
2
2
1
2
2
3
3
3
2
8
Short-Term Debt
0
0
0
1
0
1
0
0
0
0
0
0
0
0
1
Other Current Liabilities
0
0
0
2
1
2
0
0
0
0
0
0
0
28
23
Total Current Liabilities
0
0
0
2
1
5
3
3
5
4
4
5
6
36
45
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
5
5
5
6
6
7
8
Minority Interest
0
0
0
0
0
0
0
0
0
0
1
1
1
4
10
Other Liabilities
0
0
0
0
0
0
0
0
0
1
1
1
0
0
1
Total Liabilities
0
N/A
0
N/A
0
N/A
2
N/A
1
-39%
5
+271%
3
-52%
3
+28%
10
+200%
10
+5%
10
+1%
11
+10%
13
+14%
47
+264%
63
+36%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Retained Earnings
0
0
0
6
9
17
28
40
53
71
96
130
162
201
239
Additional Paid In Capital
0
0
0
5
8
34
50
68
80
104
228
232
253
271
306
Total Equity
0
N/A
0
N/A
0
N/A
1
N/A
1
+14%
17
N/A
22
+30%
28
+27%
27
-3%
34
+24%
132
+292%
103
-22%
91
-12%
70
-23%
68
-4%
Total Liabilities & Equity
0
N/A
0
N/A
0
N/A
2
N/A
1
-56%
22
+3 043%
24
+11%
31
+27%
37
+18%
44
+19%
142
+225%
114
-20%
104
-9%
117
+13%
131
+12%
Shares Outstanding
Common Shares Outstanding
1
1
1
2
2
5
8
16
29
56
146
146
6
7
18

See Also

Summary
CTXR intrinsic value, competitors valuation, and company profile.
DCF Valuation
CTXR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CTXR stock valuation using valuation multiples.
Wall Street Estimates
CTXR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CTXR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 320,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.